跳至主要内容
临床试验/NCT01733472
NCT01733472已完成不适用

General Versus Intrathecal Anaesthesia for Patients Undergoing Elective Total Hip Arthroplasty

Region Skane1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Region Skane
入组人数
120
试验地点
1
主要终点
Length of Hospital Stay

研究概览

简要总结

The purpose of this study is to determine whether general anaesthesia or regional anaesthesia is best for patients undergoing Total Hip Arthroplasty.

详细描述

A randomized controlled trial (RCT) with a follow up time of 48 hrs. Patients scheduled for primary Total Hip Arthroplasty. A total of 120 patients randomly assigned to one of the two alternatives (general anaesthesia (GA) or regional anaesthesia (RA)).

General anaesthesia compared to intrathecal anaesthesia will give shorter length of hospital stay (LOS) for patients undergoing total hip arthroplasty (THA).

Primary endpoint:

LOS.

Secondary endpoints:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
46 Years 至 84 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with osteoarthritis scheduled for surgery
  • patients that will require THA
  • patients over 45 yrs and under 85 yrs.
  • patients that understand the given information and are willing to participate in this study
  • patients who have signed the informed consent document.
  • patients belonging to ASA class I-III.

排除标准

  • prior surgery to the same hip
  • patients with a history of stroke, neurological or psychiatric disease that potentially could affect the perception of pain
  • obesity (BMI > 35)
  • active or suspected infection
  • patients taking opioids or steroids
  • patients suffering from rheumatoid arthritis or an immunological depression
  • patients who are allergic to any of the drugs being used in this study

研究组 & 干预措施

RA-arm

Placebo Comparator

RA-arm: the patients in this arm will receive intrathecal anaesthesia consisting of bupivacaine 15 mg

干预措施: RA-arm (Drug)

GA-arm, remifentanil

Experimental

GA-arm: patients in this arm will receive general anaesthesia consisting of Target Controlled Infusion (TCI) of remifentanil and propofol

干预措施: GA-arm, remifentanil (Drug)

结局指标

主要结局

Length of Hospital Stay

时间窗: Up to 4 days after surgery

Time from the end of surgery until the patients meets the discharge criteria will be evaluated. Discharge criteria: able to get in and out of bed, Able to get dressed. Able to sit down in a chair and get up again. Able to walk 50 meters wit/without crutches. Able to flex knee 70 degrees. Able to walk stairs. Pain manageable with oral analgesics. Acceptance to be discharged

次要结局

  • Post Operative Pain(from end of surgey until 48 hrs later)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Harsten

M.D.

Region Skane

研究点 (1)

Loading locations...

相似试验